Related Experiment Video

Updated: May 15, 2026

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration
10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

MEK inhibition induced downregulation of MRP1 and MRP3 expression in experimental hepatocellular carcinoma

Shibo Lin1, Katrin Hoffmann1, Zhi Xiao2

  • 1Department of General and Transplant Surgery, Ruprecht-Karls-University, Im Neuenheimer Feld 110, Heidelberg, 69120, Germany.

Cancer Cell International
|January 17, 2013
PubMed
Abstract

Insights

MEK inhibitors sensitize hepatocellular carcinoma (HCC) cells to chemotherapy by reducing drug efflux proteins MRP1 and MRP3. This combination therapy enhances intracellular drug accumulation, offering a new treatment strategy for drug-resistant HCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) exhibits significant drug resistance, hindering chemotherapy efficacy.
  • Overexpression of ATP binding cassette (ABC) proteins in HCC is linked to mitogen-activated protein kinase (MAPK) pathway activation.
  • This study investigates MAPK pathway inhibition's impact on HCC growth and ABC proteins MRP1 and MRP3 expression.

Purpose of the Study:

  • To evaluate the effects of MAPK pathway inhibitors on HCC cell growth.
  • To determine the role of MAPK inhibition in regulating MRP1 and MRP3 expression in HCC.
  • To assess the potential of combining MEK inhibitors with chemotherapy for resistant HCC.

Main Methods:

  • Treatment of HCC cells with Raf1 inhibitor (GW5074) and MEK inhibitors (U0126, AZD6244).
  • Assessment of cell viability, MAPK pathway activation (Western blot), and MRP1/MRP3 protein levels.
  • Measurement of intracellular doxorubicin accumulation via flow cytometry.

Main Results:

  • Both Raf1 and MEK inhibitors suppressed HCC cell growth dose-dependently.
  • MEK inhibitors sensitized HCC cells to gemcitabine and doxorubicin chemotherapy.
  • MEK inhibitors reduced phosphorylated ERK, decreased MRP1/MRP3 expression, and increased intracellular doxorubicin accumulation.

Conclusions:

  • MEK inhibitors sensitize HCC cells to chemotherapy by increasing intracellular drug accumulation.
  • Reduced MRP1 and MRP3 expression by MEK inhibitors contributes to chemotherapy sensitization.
  • Combining MEK inhibitors with conventional chemotherapy presents a promising therapeutic strategy for resistant HCC.

More Related Videos

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma07:47

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...